Celeste Dang

IL-33 Signaling Alters Regulatory T Cell Diversity in Support of Tumor Development

Amy Li, Rebecca H. Herbst, David Canner et al. · Cell Reports · 2019 · 84 citations · Full text

Life Sciences, Immunology, Oncology +17

Enhanced adaptive immune responses in lung adenocarcinoma through natural killer cell stimulation

Leah Schmidt, Banu Eskiocak, Ryan Kohn et al. · Proceedings of the National Academy of Sciences · 2019 · 81 citations · Full text

Life Sciences, Immunology, Oncology +17

Deconvoluting global cytokine signaling networks in natural killer cells

Gabriela M. Wiedemann, Endi K. Santosa, Simon Grassmann et al. · Nature Immunology · 2021 · 63 citations · Full text

Life Sciences, Cell Biology, Immunology +14

Perioperative chemotherapy of oxaliplatin combined with S-1 (SOX) versus postoperative chemotherapy of SOX or oxaliplatin with capecitabine (XELOX) in locally advanced gastric adenocarcinoma with D2 gastrectomy: A randomized phase III trial (RESOLVE trial)

J. Ji, Lei Shen, Z. Li et al. · Annals of Oncology · 2019 · 42 citations · Full text

Medicine, Oncology, Surgery +15

Cutting Edge: Heterogeneity in Cell Age Contributes to Functional Diversity of NK Cells

Nicholas M. Adams, Carlos Díaz-Salazar, Celeste Dang et al. · The Journal of Immunology · 2020 · 34 citations · Full text

Life Sciences, Cell Biology, Immunology +17